Suppr超能文献

受体数量对用人类β2肾上腺素能受体转染的CHO-K1细胞中沙美特罗刺激基因转录的影响。

Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.

作者信息

McDonnell J, Latif M L, Rees E S, Bevan N J, Hill S J

机构信息

Institute of Cell Signalling and School of Biomedical Sciences, Medical School, Queen's Medical Centre, Nottingham.

出版信息

Br J Pharmacol. 1998 Oct;125(4):717-26. doi: 10.1038/sj.bjp.0702139.

Abstract
  1. The beta2-agonist salmeterol is a potent relaxant of airway smooth muscle with a long duration of action. Previous studies of cyclic AMP accumulation, however, have indicated that salmeterol is a low efficacy beta2-agonist when compared to isoprenaline. Here we have compared the properties of salmeterol and isoprenaline as stimulants of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor to different levels (50 and 310 fmol mg protein(-1)). 2. Gene transcription was monitored using a secreted placental alkaline phosphate (SPAP) reporter gene under the transcriptional control of six cyclic AMP response element (CRE) sequences. 3. In the lower expressing cells (CHO-beta2/6), salmeterol produced a maximal cyclic AMP response that was only 22% that of that obtained with isoprenaline. In contrast in the higher expressing cells (CHO-beta2/ 4), the two maxima were of similar magnitude. 4. Salmeterol was a more potent stimulant of gene transcription, producing the same maximal response as isoprenaline in both cell lines. Furthermore, in the CHO-beta2/4 cells, Salmeterol was 50 fold more potent as a stimulant of SPAP secretion than of cyclic AMP accumulation. In contrast, isoprenaline was 24 fold less sensitive as a stimulant of SPAP secretion than of cyclic AMP accumulation. In the presence of serum (10%), the effects of both salmeterol and isoprenaline on gene transcription were augmented. 5. These data suggest that the low efficacy and/or long duration of action of salmeterol, favours a potent stimulation of gene transcription when compared to more efficacious but shorter-lived agonists such as isoprenaline.
摘要
  1. β2肾上腺素能激动剂沙美特罗是一种作用持续时间长的强效气道平滑肌松弛剂。然而,先前关于环磷酸腺苷(cAMP)积累的研究表明,与异丙肾上腺素相比,沙美特罗是一种低效的β2肾上腺素能激动剂。在此,我们比较了沙美特罗和异丙肾上腺素作为基因转录刺激剂的特性,这些基因转录发生在转染了不同水平(50和310 fmol mg蛋白-1)人β2肾上腺素能受体的CHO-K1细胞中。2. 使用在六个环磷酸腺苷反应元件(CRE)序列转录控制下的分泌型胎盘碱性磷酸酶(SPAP)报告基因监测基因转录。3. 在低表达细胞(CHO-β2/6)中,沙美特罗产生的最大cAMP反应仅为异丙肾上腺素的22%。相比之下,在高表达细胞(CHO-β2/4)中,两者的最大值大小相似。4. 沙美特罗是一种更有效的基因转录刺激剂,在两种细胞系中产生与异丙肾上腺素相同的最大反应。此外,在CHO-β2/4细胞中,沙美特罗作为SPAP分泌刺激剂的效力比作为cAMP积累刺激剂的效力高50倍。相比之下,异丙肾上腺素作为SPAP分泌刺激剂的敏感性比作为cAMP积累刺激剂的敏感性低24倍。在有血清(10%)存在的情况下,沙美特罗和异丙肾上腺素对基因转录的作用均增强。5. 这些数据表明,与异丙肾上腺素等更有效但作用时间较短的激动剂相比,沙美特罗的低效和/或长作用时间有利于对基因转录的强效刺激。

相似文献

引用本文的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验